Long-Term Safety of Hydrocodone Bitartrate in Patients Who Require Opioid Treatment

Study Title

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

Teva Identifier

C33237/3080

ClinicalTrials.gov Identifier

NCT01223365

Study Status

Completed

Trial Condition(s)

Chronic Pain

Interventions

Drug: Hydrocodone ER

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
pain icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 80 Years

Trial Duration

10/01/2010 - 09/01/2012

Phase

Phase 3

Study Type

Interventional